Skip to main content

Omega Therapeutics, Inc.

OMGADelisted Mar 20, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001850838

Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Omega Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of OMGA: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders4552+7
Shares42.5M43.5M+1.07M (+2.5%)
Value$480.2M$271.7M−$208.4M (−43.4%)

New holders (12)

Institutions that held Omega Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to OMGA in Q1 2022
InstitutionSharesValue% of portfolio
Nuveen Asset Management, LLC31,685$219.0K0.00%
Millennium Management LLC22,494$140.0K0.00%
Barclays PLC16,995$106.0K0.00%
Rhumbline Advisers15,329$96.0K0.00%
D. E. Shaw & Co., Inc.13,437$84.0K0.00%
Two Sigma Investments, LP10,607$66.0K0.00%
Amalgamated Bank2,981$19.0K0.00%
Amalgamated Financial Corp.2,981$19.0K0.00%
Point72 Hong Kong Ltd602$4.00K0.00%
TD Waterhouse Canada Inc.240$1.57K0.00%
Simplex Trading, LLC2$00.00%
Ellevest, Inc.7$00.00%

Sold out (5)

Institutions that held Omega Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of OMGA in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Sphera Funds Management Ltd.352,948$4.00M
State of Michigan Retirement System294,117$3.33M
Bank of Montreal74,725$1.07M
Jane Street Group, LLC17,927$203.0K
Signet Financial Management, LLC1,000$11.0K